# Developmental Exposures, Stem Cell Reprogramming, and Breast Cancer Disparities

> **NIH NIH R01** · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 2024 · $634,304

## Abstract

Abstract. This application is to renew R01ES028802, Dr. Colacino’s Outstanding New Environmental Scientist
(ONES) award. The goal of this project is to define the impacts of chemical exposures on breast cancer
disparities. There are profound breast cancer disparities by race. African American women are two to three
times more likely to be diagnosed with the most aggressive subtype, triple negative, and 40% more likely to die
of breast cancer. The etiological drivers of these disparities are complex and multifactorial. We have identified
stark racial disparities in chemical biomarkers in US women across a multitude of toxicants. Our preliminary
data show that many of these chemicals have breast cancer associated functional and molecular bioactivity at
doses relevant to human exposure. Understanding how chemical exposure disparities impact aggressive
breast cancer biology and breast cancer mortality would provide us with much needed strategies for precision
prevention and identify new molecular targets for treatment. Aggressive breast cancers are characterized by
the acquisition of the Hallmarks of Cancer, promoted by the environmental via the Key Characteristics of
Carcinogens. Reflected in the 2022 updated Hallmarks, data from us and others shows that aggressive breast
cancers acquire a “stem cell-like” phenotype through dysregulation of developmental pathways or the
expansion of stem cells. Intriguingly, our preliminary data using high throughput transcriptomic profiling of 19 of
these chemicals shows that multiple exposures, including p,p’-DDE and lead, induce phenotypic plasticity in
non-transformed breast cells. Here, we will integrate human exposure data, publicly available toxicity data, and
high throughput in vitro characterization of chemical effects in normal breast cells from diverse donors, with
external validation in molecular epidemiology datasets. Based on our previous findings and preliminary data,
our hypothesis is that these chemicals will promote cancer hallmarks and the acquisition of stemness at human
relevant doses and will be associated with breast cancer mortality and aggressive breast cancer molecular
profiles. Aim 1 will quantify dose-dependent functional and transcriptional effects of exposure disparity
chemicals. Aim 2 will define impacts of exposure disparities chemicals on the acquisition of hybrid stem cell
states. Aim 3 will quantify chemical exposure disparities in breast cancer mortality and outcomes. We propose
an epidemiologically-informed precision toxicology approach that we expect will determine key chemical
drivers of aggressive breast cancers and their molecular targets. Understanding how chemical exposures
impact health disparities is urgently needed for new prevention and treatment strategies.

## Key facts

- **NIH application ID:** 10755358
- **Project number:** 5R01ES028802-07
- **Recipient organization:** UNIVERSITY OF MICHIGAN AT ANN ARBOR
- **Principal Investigator:** Justin Adam Colacino
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $634,304
- **Award type:** 5
- **Project period:** 2018-01-01 → 2027-10-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10755358

## Citation

> US National Institutes of Health, RePORTER application 10755358, Developmental Exposures, Stem Cell Reprogramming, and Breast Cancer Disparities (5R01ES028802-07). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10755358. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*